Nephros(US:NEPH) Globenewswire·2025-11-06 21:10Core Insights - Nephros, Inc. reported a net revenue of $4.8 million for Q3 2025, marking a 35% increase from $3.5 million in Q3 2024, and achieved profitability for the fourth consecutive quarter [1][2][3] Financial Performance - Net income for Q3 2025 was $337,000, an 84% increase from $183,000 in Q3 2024 [2][7] - Adjusted EBITDA for Q3 2025 rose 42% to $418,000 compared to $295,000 in Q3 2024 [2][7] - For the nine months ended September 30, 2025, net revenue increased 37% to $14.1 million from $10.3 million in the same period of 2024 [8][12] - Net income for the nine months was $1.1 million, a turnaround from a net loss of $275,000 in the same period of 2024 [12] Revenue Breakdown - Core programmatic revenue grew by 51% in Q3 2025 compared to Q3 2024, driven by strong reorders and new active sites [3][8] - Service revenue also saw significant growth, contributing to the overall increase in net revenue [3][8] Cost and Expenses - Cost of goods sold for Q3 2025 was $1.9 million, up from $1.4 million in Q3 2024, maintaining a gross margin of 61% [4] - Selling, general, and administrative expenses increased by 30% to approximately $2.2 million due to higher sales commissions and employee bonuses [5] - Research and development expenses rose 80% to approximately $0.3 million, reflecting increased employee bonuses and salary expenses [6] Cash Position - As of September 30, 2025, Nephros had cash and cash equivalents of approximately $5.2 million, up from $3.8 million at the end of 2024, and remains debt-free [13]